Horckmans M, Léon-Gómez E, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D. Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise. Am J Physiol Heart Circ Physiol 303: H835-H843, 2012. First published August 3, 2012; doi:10.1152/ajpheart.00256.2012.-Nucleotides released within the heart under pathological conditions can be involved in cardioprotection or cardiac fibrosis through the activation purinergic P2Y2 and P2Y6 receptors, respectively. We previously demonstrated that adult P2Y4-null mice display a microcardia phenotype related to a cardiac angiogenic defect. To evaluate the functional consequences of this defect, we performed here a combination of cardiac monitoring and exercise tests. We investigated the exercise capacity of P2Y4 wild-type and P2Y4-null mice in forced swimming and running tests. Analysis of their stress, locomotion, and resignation was realized in open field, black and white box, and tail suspension experiments. Exercise-induced cardiac hypertrophy was evaluated after repeated and prolonged exercise in P2Y4 wild-type and P2Y4-null hearts. We showed that P2Y4-null mice have a lower exercise capacity in both swimming and treadmill tests. This was not related to decreased motivation or increased stress, since open field, white and black box, and mouse tail suspension tests gave comparable results in P2Y4 wild-type and P2Y4-null mice. Heart rate and blood pressure rose normally in P2Y4-null swimming mice equipped with a telemetric implant. On the contrary, we observed a delayed recovery of postexercise blood pressure after exercise in P2Y4-null mice. The heart rate increment in response to catecholamines was also similar in P2Y4 wild-type and P2Y4-null implanted mice, which is consistent with a similar level of cardiac ␤-receptor expression. Interestingly, the heart of P2Y4-null mice displayed a reduced sympathetic innervation associated with a decreased norepinephrine level. We also demonstrated that exercise-induced cardiac hypertrophy was lower in P2Y4-null mice after repeated and prolonged exercise. This was associated with a lower increase in cardiomyocyte size and microvessel density.
myocardial function (28) . The involvement of purinergic P2Y 2 receptors in the UTP-mediated cardioprotection in vivo has been recently demonstrated (6) . Important amounts of extracellular nucleotides are secreted within the heart, especially under ischemia (9) or pressure overload (18) . Furthermore, ATP and its degradation products were reported to participate to a negative feedback mechanism matching coronary blood flow to myocardial oxygen consumption during exercise (10) .
Diverse actions of extracellular nucleotides acting at both ionotropic P2X receptors and G protein-coupled P2Y receptors have been described in many cell types (1) . The human P2Y 4 receptor is a UTP receptor coupled to the phosphoinositide/ Ca 2ϩ pathway, encoded by a gene located on chromosome X and displaying a very restricted tissue distribution (7) . The murine ortholog of human P2Y 4 receptor is activated by UTP and ATP (4, 15, 26) , as described for the ubiquitously expressed mouse P2Y 2 receptor (16) . Interestingly, P2Y 2 and P2Y 4 receptors were abundantly detected in the rat developing heart (5). P2Y 4 -null mice have been generated in our laboratory (21) and display a microcardia phenotype (11) . This was explained by a decreased heart weight increase during early postnatal development resulting from an angiogenic defect related to the expression of P2Y 4 on cardiac microvascular endothelial cells (11) .
Here we demonstrate that P2Y 4 -deficient mice display lower exercise capacity and a reduced effort-induced adaptive cardiac hypertrophy.
MATERIALS AND METHODS

Ethics Statement
All animal work has conducted according to relevant national and international guidelines and approved by the Ethics Committee of the Free University of Brussels.
Animals and Drugs
P2Y 4
0/ϩ and P2Y 4 0/Ϫ CD1/C57Bl6 male mice were generated in our institute as described (14) . Anti-CD31 (platelet endothelial cell adhesion molecule-1) and the rat isotype IgG2 antibodies were purchased from BD Biosciences (Le Pont-de-Claix, France). Anti-troponine was from Abcam (Cambridge, UK). The secondary antibodies were from Jackson ImmunoResearch (Suffolk, UK). Paraformaldehyde and paraffin were from Merck Eurolab (Strasbourg, France).
Exercise Capacity of P2Y 4 0/ϩ and P2Y 4 0/Ϫ Mice
Swimming tests without cardiac monitorin. A 4-liter beaker filled with water was used to assess the exercise tolerance of mice (20) . Briefly, a weight (2.5% of their body weight) was attached to the tail of the mice, and they were placed in the water and their behavior was observed. Swim-trained mice were then placed in the water. The time at which the mouse was unable to maintain buoyancy was recorded, and it was immediately removed from the beaker. For the experiments with repeated swimming tests, a 10-liter beaker was used as a swimming pool to assess the exercise adaptation of male mice. Swim-trained mice were placed in the water during 90 min, twice a day. After 3 wk, the animals were euthanized and the hearts collected for further analysis.
Motorized treadmill. Individual mice were placed on a motorized treadmill with a mild motivational shock bar (Eco-6M Treadmill; Columbus Instruments, Columbus, OH). Exercise capacity was quantified by the number of breaks during 5 min at a speed of 13 or 16 m/min.
Stress and Locomotion Tests
Open field experiments. P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice were placed in a 40 ϫ 40 cm field surrounded by wall under dim light (15 lux). Activity was measured for 30 min to assess total distance traveled, the time spent in the central zone (area Ͼ 10 cm from walls), the latency to enter in zone, and the frequency in zone. Activity during the open field was recorded and videotaped via an overhead camera. Open field data were automatically analyzed by a computer-operated tracking system (Noldus Information Technology). The test was performed on 20 mice from each group.
Black and white box test. In the black and white two-compartment box used here, an opening was located centrally at floor level, connected the both compartments. A dark box was painted black and covered with a lid. The other box (not covered) was painted white and lit by a light (400 lx). At the start of the session, the mice were placed in the white compartment, head facing a corner. The time spent in the lit box was noted during the 10-min period of the test. A camera located above the test box was used to observe the animal. The data were automatically analyzed by a computer-operated tracking system (Noldus Information Technology). The test was performed on 20 mice from each group.
Tail suspension test. The mouse was hung on the hook by an adhesive tape placed 20 mm from the extremity of its tail, and it was kept away from the nearest object. The time before immobility periods (time before resignation) and the number of movements were measured by an observer in a blinded fashion. Each mouse was used only once for each experimental session.
Swimming Tests with Cardiac Monitoring
Implants were surgically inserted as follows: under anesthesia with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg), animals were kept on a heating pad throughout implantation of the blood pressure (BP) telemeter (model TA11PA-C10, Sciences International, St. Paul, MN). The left common carotid artery was isolated, and the tip of the catheter was retrogradely inserted into the aorta until the aortic arch. The catheter was connected to the body of the implant, placed in a subcutaneous pouch in the right flank. When mice had recovered from the anesthesia, they were housed in individual cages placed on top of the telemetric receivers in a light-dark cycled recording room. Mice were fed with Scientific Animal Food Engineering and water ad libitum.
After surgery recovery, mice were trained during 3 days in a 26 ϫ 20 ϫ 14 cm swimming pool starting from 5, 7, and 10 min at 35°C. Recordings were obtained during the morning when the mice were generally quiet. Each session included a 30-min recording of resting pressure, 10 min of exercise, and 20 min of recovery. To obtain pressure and heart rate (HR) values during the resting period, mice were kept in theirs cage and continuous recordings of 24 h were performed, and online recordings were digitized (range, 20 to 2,000 Hz) and stored for further analysis. Relatively low resting HR (around 500 beats/min) were indicative of full recovery and resting state. For each mouse, two recording were done in separate days.
BP signals (and HR, derived from pressure waves) from the aortic arch were measured in conscious, unrestrained animals with surgically implanted, miniaturized telemetry devices. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996).
The telemetered BP signal obtained after the magnetic activation of the probe was generated as a calibrated analog signal (UA10; DSI, St. Paul, MN). Spectral analysis using a fast Fourier transformation algorithm on sequences of 512 points was performed using the HEM 3.4 software (Notocord Systems) on systolic BP (SBP) and HR recordings. The total spectral area was examined in each mouse. The area under the curve was calculated for frequencies below 0.05 and 0.05-0.4 Hz and above 0.4 up to 5 Hz. Values were then examined for statistical changes between wild-type (WT) and knockout (KO) mice as previously described (8) .
Catecholamine Response in P2Y 4
0/ϩ -and P2Y 4 0/Ϫ -Implanted Mice Implanted mice were injected with dobutamine (20 g/g) plus atropine (1 g/g). The recording of HR was performed 5, 10, 60, and 120 min after injection. Online recordings were digitized (range, 20 to 2,000 Hz) and stored for further analysis. HR was measured in conscious, unrestrained animals with surgically implanted, miniaturized telemetry devices. The telemeter signal obtained after the magnetic activation of the probe was generated as a calibrated analog signal (UA10; DSI, St. Paul, MN). Values were then examined for statistical changes between control and treated mice.
Adrenergic Receptor Quantification in P2Y 4
0/ϩ and P2Y 4 0/Ϫ Hearts Total RNAs were extracted using TRIzol reagent (Life Technologies, Groningen, The Netherlands) and RNeasy kit column (Qiagen, Hilden, Germany) from total heart of P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice. RNA was reverse transcribed using Superscript II Reverse Transcriptase. Quantitative PCR were performed using specific primers for adrenergic receptors (␣ 1a, ␣1b, ␣1d, ␣2a, ␣2b, ␣2c, ␤1, ␤2, and ␤3). Control genes were selected for their stability after analysis using Genorm program. Ribosomal protein L13 (RPL13) and hypoxanthine phosphoribosyltransferase (HPRT) specific primers were selected using Primer Express 2.0 software and specific parameters. RT-PCR amplification mixtures contained 2 ng template cDNA. Reactions were run on a 7,500 Fast Real-Time PCR System (Applied Biosystems). Means Ϯ SE of normalized ratios were obtained using qBase software. Each assay was performed in duplicate for at least two independent preparations of heart. PCR data were normalized for each gene to RPL13 and HPRT housekeeping genes.
Catecholamine Quantification in P2Y 4 0/ϩ and P2Y 4 0/Ϫ Mice
Cardiac catecholamine measurements. Hearts of P2Y 4 0/ϩ and P2Y 4 0/Ϫ 12-wk-old mice were harvested and homogenized in 0.01 N HCl and 1 mM EDTA at 0°C. The supernatant was used to quantify norepinephrine, epinephrine, and dopamine levels, using 3-CAT research ELISA (Labor diagnostika nord), which were normalized to heart weight.
Urine catecholamine measurements. After five days of acclimatization, mice were kept in metabolic cages 24 h for determining urinary levels of dopamine, epinephrine, and norepinephrine and normalized with the level of creatinine. Water and food were allowed ad libitum. After urine collection from P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice, creatinine was quantified by the Jaffé method, whereas the concentrations of dopamine, epinephrine, and norepinephrine were measured by HPLC with electrochemical detection.
Quantification of Sympathetic Nerve Fibers in P2Y 4 0/ϩ and P2Y 4 0/Ϫ Hearts
For the quantification of sympathetic nerve fibers, analysis of immunofluorescent staining was performed on left ventricular posterior wall. Heart of seven P2Y 4 0/ϩ and seven P2Y 4 0/Ϫ mice were sectioned at a thickness of 7 m. Tissues were incubated with anti-tyrosine hydroxylase (1:200 dilution; Abcam) in 1% horse serum and 0.1% Triton in PBS overnight at 4°C. Texas red-conjugated anti-sheep IgG from donkey was used as secondary antibody for the tyrosine hydroxylase staining. The surface labeled with the antibody against tyrosine hydroxylase was measured using ImageJ software. The labeled nerve fibers was qualitatively estimated from 10 randomly selected fields and expressed as the ratio of labeled nerve fiber area to total area.
Cold Challenge Experiments
Mice were single caged and transferred to a 4°C environment for 3 h. The colonic temperature was measured as an indication of core body temperature at 0, 30, 60, 120, and 180 min, respectively. A lubricated thermistor probe was inserted 2 cm into the rectum and held in place until a stabilized measurement was achieved. An average of three measurements was taken from each mouse at indicated time points.
Immunohistochemical Analysis in Cardiac Hypertrophy Experiments
After cervical dislocation, hearts were harvested, weighed, and frozen directly in optimum cutting temperature compound (VWR Scientific). Heart sections (7 m) were fixed with methanol and stained with hematoxylin-eosin, 4,6-diamidino-2-phenylindole, and antibodies against CD31 or troponin. Microvessel and cardiomyocyte densities were quantified in complete transversal cross sections by examining 15 fields per section covering at least 40% of each tested heart, at ϫ20 magnification, in a blinded fashion. To quantify cardiomyocyte size, microscope lighting, focus, and field selection were optimized for distinction of cell boundaries. Fields were chosen to increase the probability of cardiomyocytes being visualized in appropriate cross section and not tangentially. Cardiomyocytes were outlined manually, and cardiomyocytes size was measured using ImageJ software.
Statistics
Data are expressed as means Ϯ SE for in vitro and vivo studies. End-point comparisons with two groups were performed using an unpaired two-tailed Student's t-test (Prism Software, version 5; GraphPad). For parallel repeated-measures studies, two-way ANOVA was used with Bonferroni post hoc evaluations to determine the significance for individual time points (Prism Software; GraphPad). Data of HR and BP during exercise were analyzed using linear mixed-effect model to account for repeated measures (SPSS Statistics Software, IBM, Chicago, IL). For all studies, P values were considered as *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001.
RESULTS
Lower Exercise Capacity of P2Y 4 -Deficient Mice
Swimming tests were performed using 12-wk-old P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice with a paper clip as light ballast (Fig. 1A) . The time at which the mouse became unable to maintain complete buoyancy was defined as point of exhaustion, and this value was significantly lower for P2Y 4 0/Ϫ mice: 15.6 Ϯ 0.8 versus 25.6 Ϯ 1.6 min for P2Y 4 0/ϩ mice (means Ϯ SE; N ϭ 8; ***P Ͻ 0.001; F ratio, 4.82) (Fig. 1A) . To further evaluate the exercise tolerance of P2Y 4 -deficient mice, we performed motorized treadmill tests with a mild motivational shock bar on 12-wk-old P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice (Fig. 1B) . Exercise capacity was quantified by the number of breaks observed when the mouse stopped running and knocked the shock bar. Breaks were counted during 5 min at speeds of 13 or 16 m/min. As shown in Fig. 1B , there was a significant increase in break counts for P2Y 4 0/Ϫ mice correlated with strong signs of tiredness.
Comparable Response to Stress in P2Y 4 0/ϩ and P2Y 4 0/Ϫ Mice
To exclude the possibility that stress, depression, or motivational factors could affect the result of exercise tests, we performed open field, white and black box, and mouse tail suspension experiments. In the open field test, the total distance traveled was indicative of the general level of activity, whereas the percentage of time spent in the center of the field was used as an index of the anxiety state of mice. No significant discrepancy was observed between P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice in the total distance traveled, time before center entry, time in center area, and the number of center entries (Fig. 2A) . The white and black box and tail suspension tests also revealed no discrepancy between P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice (Fig. 2, B and C) .
Cardiac Monitoring of P2Y 4 0/ϩ and P2Y 4 0/Ϫ Mice During Swimming Test
We decided to evaluate cardiac function during exercise by a cardiac monitoring of P2Y 4 0/ϩ -and P2Y 4 0/Ϫ -swimming mice. Adult mice were chronically equipped with telemetry implants to measure HR and BP in awaked unrestrained conditions and during a short swimming exercise (Fig. 3) . The data have been analyzed using linear mixed effects model (SPSS Statistics Software). The mean HR and BP measured over a 24-h period were not significantly different between P2Y 4 0/Ϫ and P2Y 4 0/ϩ mice (data not shown). During swimming, HR and SBP increased to the same extent in P2Y 4 -null and WT mice (Fig. 3, A and C) . Postexercise HR was not significantly different in P2Y 4 -deficient mice (Fig. 3B) . Interestingly, the postexercise BP recovery was significantly slower in P2Y 4 0/Ϫ mice (Fig. 3, C and D) , characterized by a change of 55 Ϯ 22% in the ⌬SBP, measured as the ratio between SBP 5 min after exercise and SBP during swimming. 4 WT and P2Y 4 
Catecholamine Responsiveness, Catecholamine Level, and Adrenergic Receptor Expression in P2Y
KO Mice
Injection of dobutamine (20 g/g) plus atropine (1 g/g) was performed in P2Y 4 WT and P2Y 4 KO mice to evaluate maximal increase in HR (Fig. 4, A and B) . As shown in Fig.  4A , a 10-min period of exercise (swimming) or dobutamine 0/Ϫ mice were placed in a 40 ϫ 40 cm field surrounded by wall under dim light. Activity was measured for 30 min to assess total distance traveled, the time spent in the central zone (area Ͼ10 cm from walls), the latency to enter in zone, and the frequency in zone. B: in the black and white two-compartment box, a dark box was painted black and covered with a lid, and the other box (not covered) was painted white and lit by a light. The time spent in the lit box was noted during the 10-min period of the test. C: the mouse was hung on the hook by an adhesive tape placed 20 mm from the extremity of its tail. The time before resignation and the number of movements were measured in a blinded fashion. Each mouse was used only once for each experimental session. plus atropine induced similar HR increment in P2Y 4 WT and P2Y 4 KO mice. Similar responses were observed in P2Y 4 WT and P2Y 4 KO mice at different times following injection (Fig. 4B) .
We then quantified myocardial adrenergic receptor levels ( Fig. 4C ) and catecholamine levels (Fig. 4D ) in P2Y 4 WT and P2Y 4 KO hearts. The level of ␣ 1a -, ␣ 1b -, ␣ 1d -, ␣ 2a -, ␣ 2b -, ␣ 2c -, ␤ 1 -, ␤ 2 -, and ␤ 3 -adrenergic receptors was quantified by quantitative PCR experiments using RNAs extracted from P2Y 4 WT and P2Y 4 KO whole hearts (Fig. 4C) . No difference in expression was observed for ␤-adrenergic receptors (Fig. 4C) . However, we observed a reduction of ␣ 2a -and ␣ 2c -receptor expression and an increase in ␣ 1b -expression in P2Y 4 KO hearts compared with P2Y 4 WT hearts (Fig. 4C) . Quantification of cardiac and urine level of catecholamines has provided comparable data in Fig. 4 , D and E, respectively: norepinephrine and dopamine levels were reduced, whereas epinephrine level was increased in P2Y 4 KO mice compared with P2Y 4 WT mice. More precisely, the urinary content of epinephrine (60 Ϯ 5 vs. 83 Ϯ 7 g/g creatinine; mean Ϯ SE; *P Ͻ 0.05; F ratio, 2.18) was higher in P2Y 4 0/Ϫ mice, whereas those of norepinephrine (632.9 Ϯ 27 vs. 554 Ϯ 25 g/g creatinine; mean Ϯ SE; *P Ͻ 0.05; F ratio, 1.02) and dopamine (1,181 Ϯ 129 vs. 748.0 Ϯ 77 g/g 0/ϩ and P2Y 4 0/Ϫ hearts. Total RNAs were extracted from total heart of P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice and reverse transcribed using Superscript II Reverse Transcriptase. Quantitative PCR were performed using specific primers for adrenergic receptors (␣1a, ␣1b, ␣1d, ␣2a, ␣2b, ␣2c, ␤1, ␤2, and ␤3). Ribosomal protein L13 (RPL13) and hypoxanthine phosphoribosyltransferase (HPRT) control genes were selected for their stability after analysis using Genorm program. Each assay was performed in duplicate for at least 2 independent preparations of heart. PCR data were normalized for each gene to RPL13 and HPRT housekeeping genes. creatinine; mean Ϯ SE; **P Ͻ 0.01; F ratio, 2.54) were decreased in P2Y 4 0/Ϫ mice compared with P2Y 4 0/ϩ mice (Fig. 4E) .
Reduced Cardiac Sympathetic Innervation and Decreased Response to Hypothermia in P2Y 4 0/Ϫ Mice
The decreased level of norepinephrine and expression of ␣ 2a -and ␣ 2c -receptors could be explained by a reduced sympathetic innervation of the heart. We have quantified cardiac sympathetic innervation by ␤-tyrosine hydroxylase staining of P2Y 4 0/ϩ and P2Y 4 0/Ϫ hearts (Fig. 5, A and B) . We observed a significant reduction of ␤-tyrosine hydroxylase staining in P2Y 4 0/Ϫ hearts compared with P2Y 4 0/ϩ hearts ( Fig. 5B ; P Ͻ 0.05).
We also evaluated the response to hypothermia of P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice. During cold exposure, the body temperature of P2Y 4 0/Ϫ mice decreased more rapidly than that of P2Y 4 0/ϩ mice (Fig. 5C) . After 3 h, there was a difference of 1.5 Ϯ 0.6°C between the body temperature of P2Y 4 0/ϩ and P2Y 4 0/Ϫ mice (mean Ϯ SE; **P Ͻ 0.01; N ϭ 9) (Fig. 5C ).
Reduced Cardiac Hypertrophy in Swim-Trained P2Y 4 -Deficient Mice
We also investigated the effect of a prolonged effort on heart size of P2Y 4 0/ϩ and P2Y 4 0/Ϫ adult mice (Fig. 6) . The mice have been forced to swim two periods of 90 min per day during 3 wk. We observed a significant increase in heart size that was significantly higher in P2Y 4 0/ϩ mice compared with P2Y 4 0/Ϫ mice (29 Ϯ 6 vs. 16 Ϯ 4%) (Fig. 6A) . Cardiac microvascular density was evaluated in mice subjected to repeated swimming exercise (Fig. 6, B and D) . Swim-trained P2Y 4 WT mice but not P2Y 4 -null mice displayed a significant increase in microvessel/cardiomyocyte ratio compared with control mice (Fig. 6B ). Cardiomyocyte size was higher in control P2Y 4 -null mice compared with P2Y 4 WT mice (Fig. 6, C and D) . Cardiomyocyte size was significantly increased after training in P2Y 4 WT mice but not in P2Y 4 -null mice (Fig. 6, C and D) .
DISCUSSION
P2Y 4 -null mice display a defective cardiac postnatal development related to a cardiac angiogenic defect and resulting in a decreased heart weight at adult age (11) . Here a combination of cardiac monitoring and exercise tests demonstrated that P2Y 4 -null mice displayed a lower exercise capacity, a defective BP recovery after exercise, and a reduced exercise-induced cardiac hypertrophy.
More precisely, P2Y 4 -null mice displayed reduced exercise tolerance in our two described exercise models, allowing estimation of exhaustion: motorized treadmill tests with a mild motivational shock bar and swimming tests. These results cannot be attributed to an interference with stress, locomotion, or motivational factors since the open field, black and white box, and tail suspension tests did not reveal any difference between P2Y 4 WT and KO mice.
A defect in the sympathetic system was suggested by the lower capacity of P2Y 4 -deficient mice to control their body temperature under hypothermic conditions and the lower urinary norepinephrine level. However, the HR showed normal evolution in swimming mice and dobutamine plus atropineinjected mice equipped with a telemetric implant. This was consistent with the comparable expression of ␤ 1 -and ␤ 2 -receptors in the heart of P2Y 4 -null and WT mice. Furthermore, it is known that ␤ 1 -and double ␤ 1 /␤ 2 -receptor KO mice exhibit normal performance during exercise despite a reduced increase in HR and contractility (22, 23) .
The reduced exercise capacity of P2Y 4 0/Ϫ mice could be explained by the reduced microvascular density, which results in a failure to adequately increase blood flow and oxygen supply during exercise. Purinergic receptor activation in capillary endothelial cells by nucleotides released from hypoxic erythrocytes would initiate a retrograde vasodilator signal to the upstream arteriole (1). Furthermore, nucleotides can be released from cardiomyocytes in response to mechanical stretch (18) or during myocardial ischemia (27) . We have previously shown that P2Y 4 receptor plays a major role in cardiac microvascular endothelial cell functions (11) . In addition, a decreased cardiac output during intense exercise, related to the small size of the heart, might also play a role as reported in the case of the ␣ 1A/C -␣ 1B double KO mice (19) .
Lower exercise capacity of P2Y 4 0/Ϫ mice was identified using running and swimming tests, but cardiac monitoring was exclusively performed during swimming tests because telemetry was technically incompatible with motorized treadmill device. We observed that the postexercise recovery of SBP was delayed in the P2Y 4 -null mice. Interestingly, abnormal postexercise SBP was reported to be related to the extent of exerciseinduced impairment of left ventricular function in patients with coronary artery disease or chronic heart failure (14, 17) .
During exercise, released ATP and UTP could act on cardiomyocytes expressing P2Y 2 receptors and on endothelial P2Y 2 and P2Y 4 receptors to regulate many components of the cardiac response to effort. We previously observed lower PDGF-B serum levels in P2Y 4 -null mice (11) . PDGF-B deficiency was related to cardiac disorders including myocardial hypotrophy and septal abnormalities (2) . Noteworthy, a negative effect of PDGF-B on SBP has been previously described in rats (13) . Higher SBP observed in P2Y 4 -null mice after exercise could be correlated with PDGF-B-defective regulation.
Interestingly, the angiogenic defect associated to the loss of P2Y 4 expression led to a reduced heart weight increase not only during postnatal heart development but also during the heart hypertrophic response to prolonged effort. The increase of microvessel density and cardiomyocyte size observed in P2Y 4 WT mice after prolonged and repeated effort was not significant in P2Y 4 -null mice. The lower cardiac hypertrophy in P2Y 4 0/Ϫ mice could be related to the angiogenic defect observed in these mice. Indeed, interactions between cardiac endothelial cells and cardiomyocytes are determinant for heart growth (12) , and increased angiogenesis has been shown to induce cardiac hypertrophy (24) . The loss of endothelial P2Y 4 receptor that affects postnatal heart growth could thus also reduce exercise-induced cardiac hypertrophy.
In summary, reduced exercise capacity in P2Y 4 -null mice could result from a complex mechanism involving the various defects observed in P2Y 4 KO mice, including a cardiac angio- genic defect, a reduced norepinephrine level and sympathetic innervation of the heart, and defective BP recovery after exercise. It is likely that the decreased exercise capacity is primarily related to the smaller ventricle size and lower cardiac capillary density resulting from the altered postnatal cardiac development. We have observed a decreased level of norepinephrine in the heart of P2Y 4 -null mice, associated with a decreased expression of ␣ 2a/c -receptors and tyrosine hydroxylase, indicating a reduced sympathetic innervation. The exact mechanism of this defect could be complex. Norepinephrine release have been described from ATP-, UTP-, or UDP-stimulated rat sympathetic neurons, through P2X activation (3) or P2Y 6 activation (25) . The involvement of P2Y 4 in catecholamine level and cardiac innervation could be an indirect consequence of heart development defect. Its importance remains unclear although it is known that ␣ 1A/C -␣ 1B -double KO mice have reduced exercise capacity (19) .
In conclusion, we performed a combination of cardiac monitoring and a series of exercise, stress, and locomotion tests using our P2Y 4 -null mice. These mice displayed decreased exercise capacity, defective BP recovery after exercise, reduced cardiac sympathetic innervation, and reduced exerciseinduced cardiac hypertrophy. Our study demonstrates the involvement of a nucleotide receptor in both the acute and chronic response to exercise.
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